MedPath

ormal hearing tinnitus sound therapy

Completed
Conditions
ormal hearing persons with tinnitus symptoms
Ear, Nose and Throat
Tinnitus
Registration Number
ISRCTN27770434
Lead Sponsor
Oticon A/S
Brief Summary

1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/29336133 (added 24/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Normal hearing or hearing loss not more than 25 dB between 250 Hz and 2 kHz
2. Minimum 6 months tinnitus (no upper limit)
3. Category 1 (Jastreboff & Hazell, 2004) patients with normal hearing and severe tinnitus
4. Age 18-75 years
5. Inclusion of mono or bilateral tinnitus and with moderate hyperacusis (up to 6 in VAS scale), exclusion of pathological severe anxiety and depression (THI >= 80)

Exclusion Criteria

All tinnitus aetiology excluding: Meniere, middle-external ear desease, somatosensory tinnitus under physical therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Demonstrate that the Oticon device is at least as effective as other combination/sound generator devices that are used currently<br> 2. Demonstrate that the Oticon device is more effective than other combination/sound generator devices that are used currently<br><br> In other words, to understand what makes the Ti different (better?) in comparison with other devices.<br>
Secondary Outcome Measures
NameTimeMethod
ew sounds: red or pink noise, modulated sounds, and/or ocean sounds are appreciated and preferred by patients
© Copyright 2025. All Rights Reserved by MedPath